Mark D Hauge, MD Internal Medicine - Medical Oncology Medicare: Medicare Enrolled Practice Location: 601 W Chandler St, Arlington, MN 55307 Phone: 507-964-2271 Fax: 507-964-5898 |
News Archive
Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.
A modified version of a popular low-carbohydrate, high-fat diet is nearly as effective at controlling seizures as the highly restrictive ketogenic diet, Johns Hopkins Children's Center researchers report.
The old cotton patient gowns and warmed cotton blankets are history in St. Francis' Procedural Services Department. Surgery patients can now control their warmth while wearing the Bair Paws patient adjustable warming system. The Bair Paws system combines forced-air warming and patient gowning in one step.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended June 30, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended June 30, 2010 of $29.7 million or $0.32 per common share.
› Verified 7 days ago